Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (91) 91
index medicus (76) 76
male (69) 69
female (58) 58
middle aged (55) 55
aged (46) 46
adult (42) 42
infectious diseases (38) 38
mortality (26) 26
internal medicine (25) 25
microbiology (25) 25
treatment outcome (25) 25
infective endocarditis (24) 24
medicine, general & internal (24) 24
risk factors (24) 24
endocarditis (22) 22
management (21) 21
surgery (21) 21
diagnosis (20) 20
health aspects (20) 20
pharmacology & pharmacy (20) 20
aged, 80 and over (19) 19
anti-bacterial agents - therapeutic use (18) 18
prospective studies (18) 18
care and treatment (17) 17
infections (15) 15
medicine & public health (15) 15
therapy (15) 15
colistin (13) 13
heart (13) 13
hepatitis c, chronic - drug therapy (13) 13
analysis (12) 12
gram-negative bacteria (12) 12
immunology (12) 12
infection (12) 12
prevalence (12) 12
antibiotics (11) 11
cardiac & cardiovascular systems (11) 11
risk (11) 11
transplantation (11) 11
young adult (11) 11
adolescent (10) 10
cohort studies (10) 10
endocarditis - mortality (10) 10
epidemiology (10) 10
gastroenterology & hepatology (10) 10
hepatitis c (10) 10
infectious disease (10) 10
life sciences (10) 10
prognosis (10) 10
risk-factors (10) 10
antiviral agents - therapeutic use (9) 9
interferon-alpha - therapeutic use (9) 9
recombinant proteins (9) 9
retrospective studies (9) 9
virology (9) 9
acinetobacter baumannii - drug effects (8) 8
antimicrobial therapy (8) 8
combination therapy (8) 8
endocarditis, bacterial - epidemiology (8) 8
hospital mortality (8) 8
hospitalization (8) 8
impact (8) 8
infectious medicine (8) 8
infektionsmedicin (8) 8
italy (8) 8
italy - epidemiology (8) 8
multicenter (8) 8
patients (8) 8
abridged index medicus (7) 7
acinetobacter baumannii (7) 7
age factors (7) 7
critically-ill patients (7) 7
disease (7) 7
drug resistance (7) 7
drug resistance, multiple, bacterial (7) 7
drug therapy, combination (7) 7
follow-up studies (7) 7
hepatitis (7) 7
human health and pathology (7) 7
medical research (7) 7
medicine, experimental (7) 7
outcomes (7) 7
patient outcomes (7) 7
research (7) 7
usage (7) 7
valve endocarditis (7) 7
acinetobacter infections - drug therapy (6) 6
anti-bacterial agents - pharmacology (6) 6
association (6) 6
cross infection (6) 6
echocardiography (6) 6
elderly (6) 6
endocarditis - surgery (6) 6
guidelines (6) 6
hepatitis c virus (6) 6
interferon (6) 6
medicine (6) 6
nosocomial infections (6) 6
pseudomonas-aeruginosa (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
by Emanuele Durante-Mangoni and Giuseppe Signoriello and Roberto Andini and Annunziata Mattei and Maria De Cristoforo and Patrizia Murino and Matteo Bassetti and Paolo Malacarne and Nicola Petrosillo and Nicola Galdieri and Paola Mocavero and Antonio Corcione and Claudio Viscoli and Raffaele Zarrilli and Ciro Gallo and Riccardo Utili
Clinical Infectious Diseases, ISSN 1058-4838, 8/2013, Volume 57, Issue 3, pp. 349 - 358
Background. Extensively drug-resistant (XDR) Acinetobacter baumannii may cause serious infections in critically ill patients. Colistin often remains the only... 
Intensive care units | Health outcomes | Acinetobacter baumannii | Microbial sensitivity tests | Mortality | Acinetobacter | Infections | Hospitalization | ARTICLES AND COMMENTARIES | Dosage | Arm | Treatment efficacy | Ventilator-associated pneumonia | Antimicrobial therapy | Treatment safety | INFECTIOUS DISEASES | MULTIDRUG-RESISTANT | ventilator-associated pneumonia | antimicrobial therapy | MICROBIOLOGY | IMMUNOLOGY | ATTRIBUTABLE MORTALITY | NOSOCOMIAL INFECTIONS | treatment safety | GRAM-NEGATIVE BACTERIA | GLOBAL SPREAD | mortality | MULTIRESISTANT | MOLECULAR EPIDEMIOLOGY | INTRAVENOUS COLISTIN | CRITICALLY-ILL PATIENTS | treatment efficacy | NEPHROTOXICITY | Length of Stay | Intensive Care Units | Tertiary Care Centers | Humans | Middle Aged | Acinetobacter Infections - drug therapy | Critical Illness | Male | Treatment Outcome | Acinetobacter Infections - mortality | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - methods | Drug Resistance, Multiple, Bacterial | Survival Analysis | Aged, 80 and over | Acinetobacter baumannii - isolation & purification | Adult | Colistin - therapeutic use | Female | Rifampin - therapeutic use | Aged | Acinetobacter baumannii - drug effects | Usage | Colistin | Patient outcomes | Dosage and administration | Drug therapy, Combination | Drug therapy | Rifampin | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Global spread of drug-resistant Acinetobacter baumannii: Molecular epidemiology and management of antimicrobial resistance
by Durante-Mangoni, Emanuele and Zarrilli, Raffaele
Future Microbiology, ISSN 1746-0913, 04/2011, Volume 6, Issue 4, pp. 407 - 422
Acinetobacter baumannii is an opportunistic Gram-negative pathogen with increasing relevance in a variety of hospital-acquired infections especially among... 
molecular epidemiology | antimicrobial therapy | resistance genes | Acinetobacter baumannii | infection control | antiseptics | VENTILATOR-ASSOCIATED PNEUMONIA | SPECTRUM BETA-LACTAMASE | MICROBIOLOGY | BORNE BLA(OXA-58) GENE | MULTIDRUG EFFLUX PUMP | GRAM-NEGATIVE BACTERIA | INTENSIVE-CARE-UNIT | NEW-YORK-CITY | PSEUDOMONAS-AERUGINOSA | CRITICALLY-ILL PATIENTS | IN-VITRO ACTIVITY | Acinetobacter Infections - diagnosis | DNA, Ribosomal Spacer | DNA Fingerprinting | Humans | Acinetobacter Infections - drug therapy | Acinetobacter baumannii - pathogenicity | Sulbactam - therapeutic use | Sulbactam - pharmacology | Infection Control - methods | Anti-Bacterial Agents - therapeutic use | Colistin - pharmacology | Molecular Epidemiology | Acinetobacter Infections - epidemiology | Cross Infection - microbiology | Colistin - therapeutic use | Anti-Bacterial Agents - pharmacology | Acinetobacter baumannii - drug effects | Drug Resistance, Multiple, Bacterial - genetics | RNA, Ribosomal, 16S | Acinetobacter Infections - microbiology | Infection | Epidemics | Intensive care units | Pathogens | Hospitals | Disinfectants | Opportunist infection | Antimicrobial agents | Drug resistance | Epidemiology
Journal Article
Details down arrow
3. Full Text Electrophysiological Adverse Effects of Direct Acting Antivirals in Patients With Chronic Hepatitis C
by Durante‐Mangoni, Emanuele and Parrella, Antonio and Vitrone, Martina and Rago, Anna and Pafundi, Pia Clara and Nigro, Gerardo and Utili, Riccardo and Russo, Vincenzo
The Journal of Clinical Pharmacology, ISSN 0091-2700, 07/2017, Volume 57, Issue 7, pp. 924 - 930
Recently, several cases of symptomatic, sometimes fatal bradycardia during the first days of direct‐acting antiviral (DAA) (eg, sofosbuvir [SOF])... 
sofosbuvir | direct antiviral agents | arrhythmia | hepatitis C | electrocardiography | AMIODARONE | MARKER | DISPERSION | RISK | RIBAVIRIN | LEDIPASVIR | ATRIAL-FIBRILLATION | TREATMENT-NAIVE | GENOTYPE 1 INFECTION | PHARMACOLOGY & PHARMACY | Sofosbuvir - therapeutic use | Antiviral Agents - pharmacology | Humans | Middle Aged | Risk Factors | Male | Hepatitis C, Chronic - drug therapy | Bradycardia - chemically induced | Electrocardiography | Female | Aged | Sofosbuvir - adverse effects | Cohort Studies | Antiviral agents | Usage | Care and treatment | Electrocardiogram | Electrophysiology | Dosage and administration | Hepatitis C | Cardiac arrhythmia | Hepatitis | Therapy | P waves | Bradycardia | Parameters | Syncope | Interferon | Hepatitis C virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Reply to Letter: Influence of Liver and Kidney Disease on Sofosbuvir Electrophysiological Effects
by Vitrone, Martina and Parrella, Antonio and Durante‐Mangoni, Emanuele
The Journal of Clinical Pharmacology, ISSN 0091-2700, 07/2017, Volume 57, Issue 7, pp. 933 - 934
PHARMACOLOGY & PHARMACY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration
by Zampino, Rosa and Pisaturo, Maria A and Cirillo, Grazia and Marrone, Aldo and Macera, Margherita and Rinaldi, Luca and Stanzione, Maria and Durante-Mangoni, Emanuele and Gentile, Ivan and Sagnelli, Evangelista and Signoriello, Giuseppe and del Giudice, Emanuele Miraglia and Adinolfi, Luigi E and Coppola, Nicola
Annals of Hepatology, ISSN 1665-2681, 2015, Volume 14, Issue 1, pp. 75 - 82
Hepatocellular carcinoma (HCC) is a development of severe liver disease frequently due to HBV and/or HCV infection. The aim of this retrospective study was to... 
HCC | Chronic hepatitis | Risk factors | RISK-FACTORS | METAANALYSIS | GENOTYPE | HEPATITIS-C-VIRUS | LIVER STEATOSIS | DIABETES-MELLITUS | B-VIRUS | PNPLA3 I148M | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | VIRAL-HEPATITIS | Carcinoma, Hepatocellular - epidemiology | Age Factors | Fatty Liver - pathology | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Viral Load | Liver Cirrhosis - epidemiology | Young Adult | Liver Neoplasms - epidemiology | Time Factors | Carcinoma, Hepatocellular - genetics | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Retrospective Studies | Hepatitis C, Chronic - epidemiology | Severity of Illness Index | Liver Neoplasms - genetics | Hepatitis B, Chronic - epidemiology | Membrane Proteins - genetics | Risk Factors | Blood Glucose | Coinfection - epidemiology | DNA, Viral - blood | Carcinoma, Hepatocellular - pathology | Hepatitis B virus - genetics | Liver Cirrhosis - pathology | Aged | Fatty Liver - epidemiology | Longitudinal Studies | Lipase - genetics
Journal Article
Details down arrow
6. Full Text Reply to Letter: Influence of Liver and Kidney Disease on Sofosbuvir Electrophysiological Effects
: The Journal of Clinical Pharmacology
by Vitrone, Martina and Parrella, Antonio and Durante-Mangoni, Emanuele
The Journal of Clinical Pharmacology, ISSN 0091-2700, 07/2017, Volume 57, Issue 7, pp. 933 - 934
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
by Paul, Mical and Daikos, George L and Durante-Mangoni, Emanuele and Yahav, Dafna and Carmeli, Yehuda and Benattar, Yael Dishon and Skiada, Anna and Andini, Roberto and Eliakim-Raz, Noa and Nutman, Amir and Zusman, Oren and Antoniadou, Anastasia and Pafundi, Pia Clara and Adler, Amos and Dickstein, Yaakov and Pavleas, Ioannis and Zampino, Rosa and Daitch, Vered and Bitterman, Roni and Zayyad, Hiba and Koppel, Fidi and Levi, Inbar and Babich, Tanya and Friberg, Lena E and Mouton, Johan W and Theuretzbacher, Ursula and Leibovici, Leonard and Medicinska och farmaceutiska vetenskapsområdet and Institutionen för farmaceutisk biovetenskap and Uppsala universitet and Farmaceutiska fakulteten
The Lancet Infectious Diseases, ISSN 1473-3099, 04/2018, Volume 18, Issue 4, pp. 391 - 400
Colistin–carbapenem combinations are synergistic in vitro against carbapenem-resistant Gram-negative bacteria. We aimed to test whether combination therapy... 
MORTALITY | INFECTIOUS DISEASES | MULTICENTER | SAFETY | POPULATION PHARMACOKINETICS | COMBINATION THERAPY | PREDICTORS | CRITICALLY-ILL PATIENTS | METHANESULFONATE | ACINETOBACTER-BAUMANNII INFECTIONS | Care and treatment | Pneumonia | Colistin | Analysis | Bacterial pneumonia | Clinical trials | Gram-negative bacteria | Health aspects | Bacterial infections | Mortality | Bias | Systematic review | Infections | Studies | Antibiotics | Bacteria | Informed consent | Meropenem | Clinical medicine | Infectious Medicine | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Infektionsmedicin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Does this patient have Ebola virus disease?
by Tattevin, Pierre and Durante-Mangoni, Emanuele and Massaquoi, Moses
Intensive Care Medicine, ISSN 0342-4642, 11/2014, Volume 40, Issue 11, pp. 1738 - 1741
(beginning of the introduction) Ebola virus is one of the most virulent human pathogens. Since 1976, Ebola virus disease (EVD) has caused more than 20... 
Pediatrics | Pain Medicine | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Intensive / Critical Care Medicine | Anesthesiology | HEMORRHAGIC-FEVER | CLINICAL-OBSERVATIONS | CONGO | FEATURES | CRITICAL CARE MEDICINE | Africa - epidemiology | Diagnosis, Differential | Hemorrhagic Fever, Ebola - diagnosis | Hemorrhagic Fever, Ebola - epidemiology | Disease Outbreaks | Humans | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Clinical Characteristics and Outcome of Infective Endocarditis Involving Implantable Cardiac Devices
by Athan, Eugene and Chu, Vivian H and Tattevin, Pierre and Selton-Suty, Christine and Jones, Phillip and Naber, Christoph and Miró, José M and Ninot, Salvador and Fernández-Hidalgo, Nuria and Durante-Mangoni, Emanuele and Spelman, Denis and Hoen, Bruno and Lejko-Zupanc, Tatjana and Cecchi, Enrico and Thuny, Franck and Hannan, Margaret M and Pappas, Paul and Henry, Margaret and Fowler, Vance G and Crowley, Anna Lisa and Wang, Andrew and ICE-PCS Investigators, for the and ICE-PCS Investigators and Institute of Biomedicine, Department of Infectious Medicine and Sahlgrenska akademin and Institutionen för biomedicin, avdelningen för infektionssjukdomar and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
JAMA, ISSN 0098-7484, 04/2012, Volume 307, Issue 16, pp. 1727 - 1735
CONTEXT Infection of implantable cardiac devices is an emerging disease with significant morbidity, mortality, and health care costs. OBJECTIVES To describe... 
CARDIOVERTER-DEFIBRILLATOR INFECTION | MORTALITY | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | MANAGEMENT | PROGRESS | PERMANENT PACEMAKER | VALVE ENDOCARDITIS | Device Removal | Endocarditis - etiology | Pacemaker, Artificial - adverse effects | Prevalence | Prospective Studies | Cross Infection - etiology | Defibrillators, Implantable - adverse effects | Humans | Middle Aged | Cross Infection - mortality | Male | Treatment Outcome | Hospitalization | Heart Valve Diseases - etiology | Hospital Mortality - trends | Staphylococcal Infections - mortality | Tricuspid Valve | Endocarditis - mortality | Survival Analysis | Heart Valve Diseases - mortality | Female | Aged | Staphylococcal Infections - etiology | Infective endocarditis | Care and treatment | Diagnosis | Patient outcomes | Heart valve replacement | Medical equipment | Infections | Regression analysis | Mortality | Earth Sciences | Petrography | Hospital Mortality | Cross Infection | Sciences of the Universe | Pacemaker, Artificial | Staphylococcal Infections | Heart Valve Diseases | Life Sciences | Defibrillators, Implantable | Endocarditis | Infectious Medicine | Infektionsmedicin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Reply to Wilson et al
by Dickstein, Yaakov and Leibovici, Leonard and Carmeli, Yehuda and Daikos, George and Durante-Mangoni, Emanuele and Friberg, Lena E and Paul, Mical
Clinical Infectious Diseases, ISSN 1058-4838, 11/2019
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Direct antiviral treatment of chronic hepatitis C in heart transplant recipients
by Vitrone, Martina and Andini, Roberto and Mattucci, Irene and Maiello, Ciro and Atripaldi, Luigi and Durante‐Mangoni, Emanuele and Zampino, Rosa
Transplant Infectious Disease, ISSN 1398-2273, 02/2018, Volume 20, Issue 1, pp. e12813 - n/a
Direct‐acting antiviral agents (DAAs) are a safe and effective treatment for chronic hepatitis C (CHC). This may be particularly valuable for patients with... 
heart transplant | direct‐acting antiviral agents (DAAs) | sustained virological response (SVR) | chronic hepatitis C | direct-acting antiviral agents (DAAs) | SEROPOSITIVITY | SURVIVAL | INFECTIOUS DISEASES | VIRUS | RISK | IMMUNOLOGY | HCV INFECTION | TRANSPLANTATION | INTERFERON | AGENTS | Heart | Organ transplant recipients | Antiviral agents | Transplantation | Hepatitis C | Drug therapy | Hepatitis | Side effects | Allografts | Liver | Heart transplantation | Interferon | Hepatitis C virus | Liver transplantation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Colistin versus colistin plus meropenem for severe infections Authors' reply
by Paul, Mical and Carmeli, Yehuda and Daikos, George L and Durante-Mangoni, Emanuele and Theuretzbacher, Ursula and Mouton, Johan W and Leibovici, Leonard
The Lancet Infectious Diseases, ISSN 1473-3099, 05/2018, Volume 18, Issue 5, pp. 495 - 496
A study showed that both gradient-based and semi-automated devices can overestimate susceptibility to colistin.1 In our trial,2 we recruited patients who were... 
Colistin | Laboratories | Research funding | Mortality | Bacteria | Infections | Meropenem | Gram-negative bacteria | Patients
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure
by Kiefer, Todd and Park, Lawrence and Tribouilloy, Christophe and Cortes, Claudia and Casillo, Roberta and Chu, Vivian and Delahaye, Francois and Durante-Mangoni, Emanuele and Edathodu, Jameela and Falces, Carlos and Logar, Mateja and Miró, José M and Naber, Christophe and Tripodi, Marie Françoise and Murdoch, David R and Moreillon, Philippe and Utili, Riccardo and Wang, Andrew and ICE-PCS Investigators, for the
JAMA, ISSN 0098-7484, 11/2011, Volume 306, Issue 20, pp. 2239 - 2247
CONTEXT Heart failure (HF) is the most common complication of infective endocarditis. However, clinical characteristics of HF in patients with infective... 
PROPENSITY-SCORE | NATIVE VALVE ENDOCARDITIS | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | MULTICENTER | INTERNATIONAL COLLABORATION | MANAGEMENT | PROGNOSTIC-FACTORS | GUIDELINES | STAPHYLOCOCCUS-AUREUS ENDOCARDITIS | IN-HOSPITAL MORTALITY | Heart Failure - surgery | Echocardiography | Prospective Studies | Hospital Mortality | Humans | Middle Aged | Male | Mortality - trends | Cardiovascular Surgical Procedures - mortality | Heart Valves - surgery | Endocarditis - microbiology | Endocarditis - mortality | Female | Aged | Heart Failure - etiology | Endocarditis - complications | Cohort Studies | Endocarditis - surgery | Heart Failure - mortality | Heart failure | Care and treatment | Usage | Patient outcomes | Heart valve replacement | Infective endocarditis | Causes of | Risk factors | Surgical outcomes | Heart surgery | Patients | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Management of carbapenem-resistant Enterobacteriaceae infections
by Durante-Mangoni, E and Andini, R and Zampino, R
CLINICAL MICROBIOLOGY AND INFECTION, ISSN 1198-743X, 08/2019, Volume 25, Issue 8, pp. 943 - 950
Background: Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has... 
INFECTIOUS DISEASES | URINARY-TRACT-INFECTIONS | Colistin | Mortality | MICROBIOLOGY | Extensively drug-resistant | COMBINATION | Ceftazidime-avibactam | Ertapenem | Fosfomycin | GRAM-NEGATIVE BACTERIA | IMIPENEM-CILASTATIN | DOUBLE-BLIND | Clinical failure | Meropenem | Tigecycline | CRITICALLY-ILL PATIENTS | Klebsiella pneumoniae | KLEBSIELLA-PNEUMONIAE
Journal Article
Details down arrow
15. Combination therapy in severe Acinetobacter baumannii infections: An update on the evidence to date
by Durante-Mangoni, Emanuele and Utili, Riccardo and Zarrilli, Raffaele
Future Microbiology, ISSN 1746-0913, 2014, Volume 9, Issue 6, pp. 773 - 789
Acinetobacter baumannii is a drug-resistant Gram-negative pathogen increasingly causing hospital-acquired infections in critically ill patients. In this... 
combination therapy | Acinetobacter baumannii | clinical trials | antimicrobial resistance | RISK-FACTORS | GALLERIA-MELLONELLA MODEL | VENTILATOR-ASSOCIATED PNEUMONIA | SPECTRUM BETA-LACTAMASE | MICROBIOLOGY | AMINOGLYCOSIDE-RESISTANCE | POLYMYXIN-B | MOLECULAR EPIDEMIOLOGY | INTRAVENOUS COLISTIN | CRITICALLY-ILL PATIENTS | IN-VITRO ACTIVITY | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Humans | Acinetobacter Infections - drug therapy | Acinetobacter baumannii - pathogenicity | Acinetobacter baumannii - drug effects | Randomized Controlled Trials as Topic
Journal Article
Details down arrow
16. Full Text Hepatitis B core‐related antigen to detect hepatitis B virus (HBV) reactivation in heart transplant recipients with past HBV infection: A pilot study
by Iossa, Domenico and Vitrone, Martina and Liotti, Antonietta and Portella, Giuseppe and Durante‐Mangoni, Emanuele and Zampino, Rosa
Clinical Transplantation, ISSN 0902-0063, 06/2019, Volume 33, Issue 6, pp. e13574 - n/a
Hepatitis B core‐related antigen (HBcrAg) has been proposed as a new marker of hepatitis B virus (HBV) replication. We analyzed HBcrAg dynamics in 15 heart... 
heart transplant | hepatitis B core‐related antigen | HBV reactivation | hepatitis B core-related antigen | SURGERY | TRANSPLANTATION | Heart | Antigens | Medical research | Analysis | Medicine, Experimental | Organ transplant recipients | Transplantation | Hepatitis B virus | Health aspects | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Combination therapy for carbapenem-resistant Gram-negative bacteria
by Paul, M and Carmeli, Y and Durante-Mangoni, E and Mouton, J.W and Tacconelli, E and Theuretzbacher, U and Mussini, C and Leibovici, L
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2014, Volume 69, Issue 9, pp. 2305 - 2309
Carbapenem-resistant Gram-negative bacteria (CR-GNB) represent an increasing hazard in healthcare settings. A central question concerning the treatment of... 
Carbapenem-resistant Enterobacteriaceae | Acinetobacter baumannii | Colistin | Carbapenems | klebsiella pneumonia | MORTALITY | INFECTIOUS DISEASES | MONOTHERAPY | VENTILATOR-ASSOCIATED PNEUMONIA | MICROBIOLOGY | carbapenems | K.-PNEUMONIAE | ANTIBIOTIC-THERAPY | carbapenem-resistant Enterobacteriaceae | Klebsiella pneumonia | ACINETOBACTER-BAUMANNII | PHARMACOLOGY & PHARMACY | colistin | KLEBSIELLA-PNEUMONIAE | SERIOUS INFECTIONS | ENTEROBACTERIACEAE | Gram-Negative Bacterial Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | Drug Therapy, Combination - methods | beta-Lactam Resistance | Carbapenems - pharmacology | Humans | Gram-Negative Bacterial Infections - drug therapy | Treatment Outcome | Anti-Bacterial Agents - pharmacology | Gram-Negative Bacteria - isolation & purification | Randomized Controlled Trials as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text High-Dose Daptomycin Therapy for Left-Sided Infective Endocarditis: a Prospective Study from the International Collaboration on Endocarditis
by Manuela Carugati and Arnold S. Bayer and Josè M. Miró and Lawrence P. Park and Armenio C. Guimarães and Athanasios Skoutelis and Claudio Q. Fortes and Emanuele Durante-Mangoni and Margaret M. Hannan and Francisco Nacinovich and Nuria Fernández-Hidalgo and Paolo Grossi and Ru-San Tan and Thomas Holland and Vance G. Fowler Jr and Ralph G. Corey and Vivian H. Chu and Int Collaboration Endocarditis and International Collaboration on Endocarditis
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2013, Volume 57, Issue 12, pp. 6213 - 6222
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
RESISTANT | DIAGNOSIS | CHALLENGE | MULTICENTER | VANCOMYCIN | 21ST-CENTURY | BACTERICIDAL ACTIVITY | SUSCEPTIBILITY | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | STAPHYLOCOCCUS-AUREUS | ASSOCIATION | Anti-Bacterial Agents - therapeutic use | Endocarditis, Bacterial - drug therapy | Prospective Studies | Staphylococcus aureus - physiology | Humans | Middle Aged | Female | Male | Aged | Enterococcus faecalis - physiology | Daptomycin - therapeutic use | Clinical Therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Correlates and Prognostic Value of the First-Phase Hepatitis C Virus RNA Kinetics during Treatment
by Emanuele Durante-Mangoni and Rosa Zampino and Giuseppe Portella and Luigi E. Adinolfi and Riccardo Utili and Giuseppe Ruggiero
Clinical Infectious Diseases, ISSN 1058-4838, 8/2009, Volume 49, Issue 4, pp. 498 - 506
Background. Analysis of hepatitis C virus (HCV) RNA kinetics during antiviral therapy may allow estimation of the probability of response. Methods. To assess... 
Health outcomes | RNA | Interferons | Chronic hepatitis | Articles and Commentaries | Fibrosis |